37
Ongoing
clinical studies
clinical studies
At Stryker, we are driven by clinical evidence and committed to proving the safety and effectiveness of our products in treating the toughest stroke cases.
Hemorrhagic stroke studies
Our unwavering commitment to research and innovation in the treatment of hemorrhagic stroke is driven by evidence.
Coil your patients
with confidence
The TARGET Registry is an investigator-initiated prospective, multi center US registry of patients treated exclusively with Target 360 and Helical Detachable Coils led by Dr. Osama Zaidat at Mercy Health St. Vincent Hospital.
Reliably handle
small aneurysms
The ULTRA Registry is an investigator-initiated prospective, multicenter US registry of patients with small (<5mm) intracranial aneurysms treated exclusively with Target Ultra and Nano Detachable Coils led by Dr. Gaurav Jindal at the University of Maryland.
Effectively treat anterior and posterior aneurysms
The ATLAS IDE study has shown excellent results from the largest to date pivotal data with high complete occlusion and low complication rates.
Better attend to
bifurcations
The ATLAS Y-stenting subset is the largest to date retrospective subset analysis of a single-arm trial which evaluates Y-stenting treatments of bifuraction aneurysms.
Confidently manage complex aneurysms
With 6 key clinical studies and counting, the Contour Neurovascular System is proven to be effective in the treatment of aneurysms.
Acute Ischemic stroke studies
Grounded in evidence, our steadfast dedication to research and innovation allows us to provide top-tier treatments for acute ischemic stroke.
Perform thrombectomy with reliability
The ASSIST Registry is a core lab adjudicated study which captured real-world data from 1,500 subjects across 71 sites worldwide using Stryker’s Total Stroke Portfolio.
Learn more about
Stryker’s product portfolio
Contact us.
Thank you for your submission.
Stryker or its affiliated entities own, use, or have applied for the following trademarks or service marks: Contour Neurovascular System, Nano, Stryker, Target. All other trademarks are trademarks of their respective owners or holders.
The absence of a product, feature, or service name, or logo from this list does not constitute a waiver of Stryker’s trademark or other intellectual property rights concerning that name or logo.
The safety and effectiveness of Y-stenting has not been established.
Copyright © 2024 Stryker
AP003782 v2.0